A division bench of Justices Muzaffar Hussain Attar and Tashi Rabstan, while hearing a PIL yesterday, asked all the pharmaceutical companies to restrain themselves from giving gifts of any kind to doctors.
The court also directed the pharmaceutical companies not to arrange tours for doctors within the country or abroad.
"The doctors shall attend research conferences only after it is certified by the Head of the Department that it is in the interest of patient care and the concerned HODs will be at liberty to authorise the doctors to attend the literary seminars after it is certified that the same is in the interests of public," the court said.
"It is the common citizen who is caught between the devil and the deep sea and is being denuded of hard-earned money due to medicines which are, allegedly, not up to the proper standard," the court observed.
"The companies are doling out benefits which, it is stated in the petition and submitted at Bar, include giving of costly gifts and even making arrangements for tours of doctors within the country and abroad as well," the court said, adding that "it is the common man who ultimately bears the brunt of all these nefarious activities."
The court granted three weeks to all the other respondents to file their response.
The other respondents in the PIL include the state government through Chief Secretary, Commissioner of Health and Medical Education, Director of Health and Principals of Government Medical Colleges in Srinagar and Jammu.
The PIL seeks directions to initiate action against doctors involved in the commission and omission of offences, besides cancellation of their licenses.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
